We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible

By LabMedica International staff writers
Posted on 22 Apr 2025

Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. More...

For a long time, polymerase chain reaction (PCR) has been the gold standard for analyzing DNA changes. With the onset of the COVID-19 pandemic, the term "PCR" became widely recognized. However, PCR tests are expensive, time-consuming, and require specialized lab equipment and trained personnel. While PCR-based genetic testing gained significant attention during the pandemic, light-based methods are now offering a PCR-free alternative for genetic analysis.

Researchers at Osaka Metropolitan University (Osaka, Japan) have developed a groundbreaking light-induced DNA detection method that employs heterogeneous probe particles. This innovative technique enables highly sensitive and rapid genetic analysis without the need for PCR amplification. This advance promises to make genetic testing faster, more affordable, and more precise, benefiting fields like medicine, environmental science, and portable diagnostics. Unlike PCR, which amplifies DNA sequences by creating millions of copies for detection, this new approach directly identifies DNA by concentrating it and enhancing its specificity through optical forces and the photothermal effect. In their study, published in ACS Sensors, the researchers used heterogeneous probe particles, including gold nanoparticles and polystyrene microparticles, to create a detection system. These probes are short DNA sequences that are designed to bind with complementary sequences in the target DNA.

This process, known as DNA hybridization, results in the formation of detectable DNA pairs through fluorescence. The solution containing the target DNA and probe particles was then irradiated with laser light. When the particle size aligns with the laser wavelength, a phenomenon called Mie scattering occurs, which generates optical forces that move the particles and speed up DNA hybridization. The gold nanoparticles absorb the laser light, producing localized heat, also known as the photothermal effect, which further enhances the specificity of the hybridization. By eliminating the need for PCR amplification, this method reduces both the cost and complexity of genetic testing while delivering faster results. This innovation has the potential to make genetic analysis more accessible, with wide-ranging applications in healthcare and personal health tracking.

“Our light-induced method detects DNA without the need for PCR,” wrote the study’s lead authors. “Using just about five minutes of laser light irradiation, our method demonstrated great potential for accurate mutation detection with a sensitivity one order of magnitude higher than that of digital PCR. We aim to apply this PCR-free technology to high-sensitivity cancer diagnostics, quantum life science research, and even at-home or environmental DNA testing.”

Related Links:
Osaka Metropolitan University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: WashU Medicine researchers found that dozens of blood proteins shift during Alzheimer’s treatment and may help monitor the effects of the medication. (Image Credit: Matt Miller/WashU Medicine)

Blood Biomarker Patterns Could Support Monitoring of Anti-Amyloid Treatment

Patients with early-stage Alzheimer’s disease may receive anti-amyloid therapy to clear amyloid protein deposits from the brain. These treatments can slow disease progression, but they do not cure the... Read more

Molecular Diagnostics

view channel
Image: University of Florida scientists Hugh Fan, Ph.D., and John Lednicky, Ph.D., led the development of a cost-effective, accurate handheld device capable of simultaneously testing for seven different mosquito-borne viruses. (Image Credit: UF Health photo by Hannah Clark)

Portable Test Differentiates Seven Mosquito-Borne Viruses at Point of Care

Mosquito-borne viral illnesses can present with overlapping symptoms such as fever, joint pain, fatigue, and rash, making them difficult to distinguish without laboratory testing. In these settings, clinicians... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.